May 8, 2026

Bioventus Inc. (BVS) Stock Analysis: Unpacking a 38.97% Potential Upside in the Medical Devices Sector

For investors keen on the healthcare sector, Bioventus Inc. (NASDAQ: BVS) presents a captivating opportunity within the medical devices industry. This Durham, North Carolina-based company is dedicated to innovating solutions..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Evaluating a Biotech with a 61% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing attention within the biotechnology sector, not just for its innovative approach to treating diseases with unmet medical needs but also for its compelling..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Navigating Growth Amidst a -0.14% Potential Downside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is a burgeoning player in the biotechnology sector, focusing on developing innovative treatments for pediatric and adult diseases. With a market capitalization of $2.22..

MBX Biosciences, Inc. (MBX)

⚠️ No article content returned.

..

Personalis, Inc. (PSNL) Stock Analysis: Navigating a Promising 88% Upside in Healthcare Genomics

Personalis, Inc. (NASDAQ: PSNL), a pivotal player in the healthcare sector specializing in diagnostics and research, offers a compelling opportunity for investors intrigued by the burgeoning field of cancer genomics...

PureTech Health plc (PRTC) Stock Analysis: Navigating the Biotech Landscape with Clinical Innovations

PureTech Health plc (PRTC), a dynamic player in the biotechnology industry, is making waves with its innovative pipeline despite facing financial challenges. As a company based in Boston, Massachusetts, PureTech..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 234% Potential Upside

Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline aimed at revolutionizing cancer treatment. Headquartered in San Diego, California, Kura..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Through Challenges with a Focus on Talent Management Services

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a prominent player in the healthcare sector, primarily operates within the medical care facilities industry in the United States. With a market capitalization of..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a 166.97% Potential Upside in Biotech Innovation

REGENXBIO Inc. (NASDAQ: RGNX) stands out as a compelling opportunity within the biotechnology sector, offering a remarkable potential upside of 166.97%. With a market capitalization of $537.85 million, this clinical-stage..

Precigen, Inc. (PGEN) Stock Analysis: Unveiling a Potential 128.92% Upside in the Biotech Sector

For investors seeking opportunities in the high-stakes world of biotechnology, Precigen, Inc. (NASDAQ: PGEN) presents an intriguing proposition. With a current market capitalization of $1.48 billion, this U.S.-based biopharmaceutical company..

Embecta Corp. (EMBC) Stock Analysis: A High Dividend Yield and Potential Upside of 122.22%

Embecta Corp. (NASDAQ: EMBC) presents an intriguing opportunity for investors, particularly those with a keen eye for high-yield dividends and significant potential upside. Operating in the healthcare sector, specifically within..

Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Exploring a Potential 121% Upside

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a pioneering entity in the healthcare sector, is drawing investor attention with its innovative approach to medical devices, particularly in the field of bunion..

EyePoint, Inc. (EYPT) Stock Analysis: A Biotech Gem with 177% Potential Upside

EyePoint, Inc. (EYPT), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating serious retinal diseases. With a market capitalization of $1.12 billion, the..

Auna SA (AUNA) Stock Analysis: Exploring a 43% Potential Upside in the Healthcare Sector

Auna SA (AUNA), a key player in the healthcare sector, is garnering significant attention from investors due to its substantial upside potential and strategic positioning in emerging markets. Headquartered in..

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring a Promising 128% Upside Potential

COMPASS Pathways Plc (NASDAQ: CMPS) has been capturing investor attention with its pioneering approach in the mental health sector. Based in London, the company is making strides with its psilocybin..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: 47.87% Potential Upside in the Biotech Arena

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is catching the attention of investors with its promising potential upside of 47.87%, despite its current challenges. As a clinical-stage biotechnology company, Dianthus is pioneering..

Inventiva S.A. (IVA) Stock Analysis: Unpacking the 190% Upside Potential in Biotech’s Bold Bet

Inventiva S.A. (IVA), a French biopharmaceutical innovator, presents a compelling investment opportunity within the healthcare sector, specifically in the biotechnology industry. Known for its development of oral small molecule therapies..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Strong Revenue Growth and Strategic Collaborations Point to Promising Future

Investors with a keen eye on the biotechnology sector might find Theravance Biopharma, Inc. (NASDAQ: TBPH) an intriguing prospect. As a company focused on developing and commercializing innovative medicines, Theravance..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a Potential 77% Upside in the Biotech Sector

Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a pioneering company in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 77.77%. As a clinical-stage biotech firm, Taysha..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 77% Potential Upside Amidst Market Challenges

Tilray Brands, Inc. (NASDAQ: TLRY), a major player in the healthcare sector, specifically in the drug manufacturing industry, is navigating a complex landscape with its diversified portfolio that spans medical..

Search

Funds

May 8, 2026

Search

Funds

May 8, 2026

FTSE 100

Funds